1. osnaDocs
  2. Fachbereich 08 - Humanwissenschaften
  3. FB08 - Hochschulschriften

Applications and Restrictions of Integrated Genomic and Metabolomic Screening: An Accelerator for Drug Discovery from Actinomycetes?

Bitte benutzen Sie diese Kennung, um auf die Ressource zu verweisen:
https://osnadocs.ub.uni-osnabrueck.de/handle/urn:nbn:de:gbv:700-202109155367
Open Access logo originally created by the Public Library of Science (PLoS)
Langanzeige der Metadaten
DC ElementWertSprache
dc.creatorKrause, Janina-
dc.date.accessioned2021-09-15T14:17:55Z-
dc.date.available2021-09-15T14:17:55Z-
dc.date.issued2021-09-07-
dc.identifier.citationMolecules 26 (2021), 5450, MDPIger
dc.identifier.urihttps://osnadocs.ub.uni-osnabrueck.de/handle/urn:nbn:de:gbv:700-202109155367-
dc.description.abstractSince the golden age of antibiotics in the 1950s and 1960s actinomycetes have been the most prolific source for bioactive natural products. However, the number of discoveries of new bioactive compounds decreases since decades. New procedures (e.g., activating strategies or innovative fermentation techniques) were developed to enhance the productivity of actinomycetes. Nevertheless, compound identification remains challenging among others due to high rediscovery rates. Rapid and cheap genome sequencing as well as the advent of bioinformatical analysis tools for biosynthetic gene cluster identification in combination with mass spectrometry-based molecular networking facilitated the tedious process of dereplication. In recent years several studies have been dedicated to accessing the biosynthetic potential of Actinomyces species, especially streptomycetes, by using integrated genomic and metabolomic screening in order to boost the discovery rate of new antibiotics. This review aims to present the various possible applications of this approach as well as the newly discovered molecules, covering studies between 2014 and 2021. Finally, the effectiveness of this approach with regard to find new bioactive agents from actinomycetes will be evaluated.eng
dc.relationhttps://doi.org/10.3390/molecules26185450ger
dc.rightsAttribution-NonCommercial 3.0 Germany*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/3.0/de/*
dc.subjectbioactive natural productseng
dc.subjectactinomyceteseng
dc.subjectgenome miningeng
dc.subjectbiosynthetic gene clustereng
dc.subjectdereplicationeng
dc.subjectmolecular networkingeng
dc.subject.ddc570 - Biowissenschaften, Biologieger
dc.titleApplications and Restrictions of Integrated Genomic and Metabolomic Screening: An Accelerator for Drug Discovery from Actinomycetes?eng
dc.typeEinzelbeitrag in einer wissenschaftlichen Zeitschrift [article]ger
orcid.creatorhttps://orcid.org/0000-0001-5758-9811-
dc.subject.bk42.30 - Mikrobiologieger
dc.identifier.doi10.3390/molecules26185450-
Enthalten in den Sammlungen:FB08 - Hochschulschriften
Open-Access-Publikationsfonds

Dateien zu dieser Ressource:
Datei Beschreibung GrößeFormat 
Molecules_26_5450_2021_Krause.pdfArticle376,02 kBAdobe PDF
Molecules_26_5450_2021_Krause.pdf
Miniaturbild
Öffnen/Anzeigen
Zur Kurzanzeige


Diese Ressource wurde unter folgender Copyright-Bestimmung veröffentlicht: Lizenz von Creative Commons Creative Commons